Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)
European Journal of Cancer2008Vol. 44(17), pp. 2542–2545
Citations Over TimeTop 10% of 2008 papers
Carla M.L. van Herpen, Laura D. Locati, Jan Buter, José Thomas, Jan Bogaerts, Denis Lacombe, PHM de Mulder, Ahmad Awada, Lisa Licitra, J. Bernier, Jan B. Vermorken
Related Papers
- → Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer(2013)34 cited
- → Gemcitabine in brief versus prolonged low-dose infusion, both combined with carboplatin for advanced non-small cell lung cancer(2012)7 cited
- → Adenoid Cystic Carcinoma of the Head and Neck: A Report of 30 Cases1(1973)10 cited
- → 1147 Gemcitabine in resistant stage IV bladder cancer: A phase II study(1995)2 cited
- → Adenoid Cystic Carcinoma of the head and neck – a survey of current UK practice(2017)